You’re using a public version of DrugPatentWatch with 5 free searches available | Register to unlock more free searches. CREATE FREE ACCOUNT

Last Updated: May 15, 2024

Details for Patent: 6,127,425

✉ Email this page to a colleague

« Back to Dashboard

Summary for Patent: 6,127,425

Title:	Oral liquid medicine solution
Abstract:	Found is a pharmaceutical preparation which provides Tamoxifen Citrate in a liquid dosage form, viz. as an oral solution. The finding is based on a solvent comprising the following components: (a) of from 10% to 20% by weight of ethanol, (b) of from 10% to 60% by weight of a glycol; and (c) water, optionally containing additives, in a volume percentage adding up to 100% by volume. A preferred additive is sorbitol.
Inventor(s):	Tully; Roger Edward (Ilkley, GB)
Assignee:	Akzo Nobel N.V. (Arnhem, NL)
Application Number:	09/106,172
Patent Claim Types: see list of patent claims	Composition; Formulation; Dosage form; Delivery; Process;

Drugs Protected by US Patent 6,127,425

Glossary

Subscribe to access the full database, or Try a Trial
Applicant	Tradename	Generic Name	Dosage	NDA	Approval Date	TE	Type	RLD	RS	Patent No.	Patent Expiration	Product	Substance	Delist Req.	Patented / Exclusive Use	Submissiondate
>Applicant	>Tradename	>Generic Name	>Dosage	>NDA	>Approval Date	>TE	>Type	>RLD	>RS	>Patent No.	>Patent Expiration	>Product	>Substance	>Delist Req.	>Patented / Exclusive Use	>Submissiondate

Foreign Priority and PCT Information for Patent: 6,127,425

Foriegn Application Priority Data
Foreign Country	Foreign Patent Number	Foreign Patent Date
	97201964	Jun 27, 1997

International Family Members for US Patent 6,127,425

Subscribe to access the full database, or Try a Trial
Country	Patent Number	Estimated Expiration	Supplementary Protection Certificate	SPC Country	SPC Expiration
Austria	214269	⤷ Try a Trial
Germany	69804169	⤷ Try a Trial
Denmark	0893121	⤷ Try a Trial
European Patent Office	0893121	⤷ Try a Trial
Spain	2174388	⤷ Try a Trial
Japan	H1171269	⤷ Try a Trial
Portugal	893121	⤷ Try a Trial
>Country	>Patent Number	>Estimated Expiration	>Supplementary Protection Certificate	>SPC Country	>SPC Expiration

Make Better Decisions: Try a trial or see plans & pricing

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.